Stockreport

Krystal Biotech targets global VYJUVEK expansion with Italy launch in H2 2026 while maintaining 90%–95% gross margin outlook [Seeking Alpha]

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors
PDF Krish Krishnan, CEO, stated Krystal Biotech "made meaningful progress across all geographies" in 2025, with added U.S. sales capacity, accelerated demand, and internati [Read more]